300871.SZ
HVSEN Biotechnology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 22.67
−2.87%Year over year
Reported trailing growth
- Revenue
- +25.0%
- EBITDA
- —
- EBIT
- +655.6%
- EPS
- +518.4%
- Free cash flow
- +1998.1%
- Operating cash flow
- +57.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +18.0%
- EBITDA
- +50.1%
- EBIT
- +70.0%
- Net income
- +68.7%
- EPS
- +61.2%
- Free cash flow
- +193.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026